Scott PT, Pathirana J, Kato A, Tytus R, et al. A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and
Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in
Pneumococcal Vaccine-Naive Adults 18-64 Years of Age at Increased Risk of
Pneumococcal Disease, STRIDE Clin Infect Dis 2025 Nov 10:ciaf604. doi: 10.1093.
PMID: 41208546
|